Medical Electrolyte Injection Manufacturing and Formulation

The contract pertains to the sterile formulation and manufacturing of Multiple Electrolytes Injection, Type 1, USP, packaged in 500 mL bags, meeting all United States Pharmacopeia standards and requiring an 18-month shelf life. The work must be performed in compliance with stringent pharmaceutical quality and sterility protocols to ensure patient safety and regulatory adherence. The product is intended for medical use and will be delivered to a designated location at Fort Bragg with a zip code of 28310, aligning with Department of Defense supply chain requirements. This subcontract falls under the NAICS code 325412, indicating it is related to pharmaceutical preparation manufacturing. The solicitation was posted on July 27, 2026, with a response deadline of August 3, 2026, and is managed under the Medical Supply Chain Pharm FSA program. The offering is part of a broader effort to secure reliable, compliant sterile injectable solutions for military medical operations, with the selected contractor expected to demonstrate proven capability in aseptic processing, quality control, and regulatory documentation to meet the defense sector’s high standards.